ARTICLE
3 September 2025

The Price Of Non-payment: CJEU Upholds Cancellation Of Plant Variety Right

JA
J A Kemp LLP

Contributor

J A Kemp is a leading firm of European Patent and Trade Mark Attorneys. We combine independent thinking with collective excellence in all that we do. The technical and legal knowledge that we apply to the protection of our clients’ patents is outstanding in its breadth and depth. With around 100 science and technology graduates in the firm, including 50 PhDs, no area of science or technology is outside our scope. Our Patent Attorneys have collective in-depth expertise in patent law and procedure in every country of the world. The team of professionals who advise our clients on trade mark and design matters have backgrounds in major international law firms and hold qualifications as Chartered UK Trade Mark Attorneys, Solicitors and European Trade Mark Professional Representatives. Dedicated to this specialist area of intellectual property protection, the team has the expertise and resources to protect trade marks and designs in any market worldwide.
A recent judgment of the Court of Justice of the European Union (CJEU) underscores the need for Community Plant Variety Rights (CPVR) holders to respond promptly to communications from the Community Plant Variety Office...
European Union Intellectual Property

A recent judgment of the Court of Justice of the European Union (CJEU) underscores the need for Community Plant Variety Rights (CPVR) holders to respond promptly to communications from the Community Plant Variety Office (CPVO) and to pay annual fees on time. The judgment (Case C-426/24 P) dismissed an appeal by Romagnoli Fratelli SpA, whose CPVR for the 'Melrose' potato variety was cancelled by the CPVO due to non-payment of an annual fee by the prescribed deadline.

The CPVO had issued a debit note and reminder via its online platform, MyPVR, and sent emails to inform the rights holder of these uploads, followed by a further email reminder. When the payment deadline and an additional extended term had passed, the CPVR was cancelled. The rights holder subsequently filed an application for restitutio in integrum (restoration of rights for missed deadlines), arguing they had not received the notifications and that it was unlawful to use the MyPVR system for official communications. The CPVO denied this application, a ruling upheld first by the General Court and now by the CJEU.

The CJEU held that the President of the CPVO is expressly authorised under EU law to determine the means of electronic service (electronic service being expressly allowed under Regulation No 2100/94), and in view of this that MyPVR is a valid means of service for official documents. The court also noted that the rights holder had opted for electronic communication.

Crucially, the CJEU emphasised that the burden of proof rests on the CPVR holder, stating: "in order effectively to challenge the service of that debit note and of that reminder, it was for the appellant to prove that those documents had not been placed in its MyPVR user area or that it had not received the related confirmation emails, which it did not do." In other words, the fact that the rights holder had not spotted the notifications did not render the service invalid.

This judgment has important practical implications for breeders and companies managing plant variety rights portfolios. It confirms the legal standing of the MyPVR system as a means for electronic delivery of official communications and highlights the risks of overlooking official correspondence.

The message is clear: to avoid the permanent loss of valuable intellectual property rights, CPVR holders must monitor their MyPVR accounts, keep contact details current, and consider using professional representatives. In plant variety rights, diligence is the best safeguard against costly cancellations.

J A Kemp LLP acts for clients in the USA, Europe and globally, advising on UK and European patent practice and representing them before the European Patent Office, UKIPO and Unified Patent Court. We have in-depth expertise in a wide range of technologies, including Biotech and Life Sciences, Pharmaceuticals, Software and IT, Chemistry, Electronics and Engineering and many others. See our website to find out more.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More